Medical and Legal Marijuana in NJ: Practice and Policy Issues
ID: 4214WEBThe goal of this interactive webinar is to identify the changes that have occurred in the NJ Medical Marijuana Program. The history of marijuana legalization and major events that have shaped this history are discussed. Known scientific research on the benefits of medical marijuana and the risks associated with marijuana usage are covered, as well as the continued barriers to better scientific research on this topic. Interactive exercises are incorporated in order to have participants analyze child custody issues for clients who are on the NJ medical marijuana program. Other exercises include the participants discussing how treatment is impacted by medical marijuana and participants will analyze under what conditions there would be a "duty to report" a coworker on medical marijuana.
Fee: $60.00
Continuing Ed. Hours (CEH): 3.0 General
Webinar ObjectivesAt the conclusion of this webinar, participants will be able to:
Interpret three changes that have occurred since 2019 in the NJ Medicinal Marijuana Program
Determine the situations where the use of medicinal marijuana influence child custody issues
Analyze whether to continue services for a client on medicinal marijuana if their only diagnosis is cannabis use disorder
Identify at least three key historical events that shaped marijuana�s legal status in the United States
Webinar Outline9:30 am Welcome/Introduction
9:35 am The History of Marijuana Legalization in the United States
Marijuana legal status before 1937
Marijuana prohibition and Harry J. Anslinger
Marijuana prohibition 1950s and 1960s
The controlled substances act of 1970.
The influence of President Nixon and the war on drugs
Tightening of prohibitive laws from the 1980s and 1990s
10:05 am Medicinal Marijuana Ethics; Child Custody Issues
Discussion of the ethics around medicinal marijuana as it relates self-determination vs. safety issues
Medicinal marijuana parent and potential child custody issues
Interactive group exercise on a client with DCP&P involvement and on medicinal marijuana
11:05 am Understanding the Relevant Cannabinoids in Marijuana
NJ's limit of 10% THC and what that means
THC and THCA, vs. CBD. Which cannabinoids are relevant and why only one type can be present in high amounts
The effects of CBDs on THC
Introduction into the NJ medicinal marijuana program: debilitating conditions covered
Discussion of process of obtaining a Medicinal Marijuana card in NJ
11:50 am Medicinal and Legal Marijuana; Continued Treatment Implications
Discussion of the ethics around continuing to treat a client with a diagnosed cannabis use disorder who is also on medicinal marijuana
How should a clinician/program respond if probation states that treatment is required for a medicinal marijuana client
Interactive exercise: medicinal marijuana and continued treatment with a client
12:20 pm Conclusion/Q&A
Target AudienceSocial Workers and Allied Health ProfessionalsContent LevelBeginner - AdvancedWebinar Completion RequirementsTo earn CE credit, social workers must log in at the scheduled time, attend the entire course and complete an online course evaluation. Certificates of completion will be emailed within 10 business days of course completion.
System Requirements
- Operating Systems: Windows XP or higher, MacOS 9 or higher, Android 4.0 or higher
- Internet Browser: Internet Explorer 9.0 or higher, Google Chrome, Firefox 10.0 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible.
About the InstructorGlenn Duncan, LPC, LCADC, CCS, ACS, has been working in the behavioral healthcare field for thirty years. He has lectured nationally on many topics including clinical supervision. He is a Licensed Professional Counselor, a Licensed Clinical Alcohol/Drug Counselor, a Certified Clinical Supervisor, and an Approved Clinical Supervisor. Glenn is currently the owner of Advanced Counselor Training, LLC. For 15 years (2003-2018) Glenn served as the Executive Director at Hunterdon Drug Awareness Program, Inc. (HDAP).
